Susan Flavin

2.7k total citations
24 papers, 1.8k citations indexed

About

Susan Flavin is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, Susan Flavin has authored 24 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 7 papers in Immunology. Recurrent topics in Susan Flavin's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Sarcoidosis and Beryllium Toxicity Research (7 papers) and Psoriasis: Treatment and Pathogenesis (7 papers). Susan Flavin is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Sarcoidosis and Beryllium Toxicity Research (7 papers) and Psoriasis: Treatment and Pathogenesis (7 papers). Susan Flavin collaborates with scholars based in United States, Germany and United Kingdom. Susan Flavin's co-authors include Ulrich Costabel, Kim Hung Lo, Robert P. Baughman, Marc A. Judson, Marjolein Drent, B. Randazzo, Richard G. Langley, Elliot S. Barnathan, Mani S. Kavuru and Rozsa Schlenker‐Herceg and has published in prestigious journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Susan Flavin

23 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan Flavin United States	13	1.0k	1.0k	553	335	235	24	1.8k
Oliviero Rossi Italy	18	175 0.2×	460 0.4×	322 0.6×	265 0.8×	56 0.2×	60	1.1k
Alberto Pesci Italy	21	2.0k 1.9×	1.2k 1.2×	315 0.6×	16 0.0×	358 1.5×	51	2.6k
Stephanie Sproule United States	6	1.8k 1.8×	2.5k 2.4×	627 1.1×	81 0.2×	52 0.2×	10	2.7k
C.T. Leonard United Kingdom	18	694 0.7×	370 0.4×	227 0.4×	24 0.1×	159 0.7×	51	1.2k
Thomas El Jammal France	11	268 0.3×	302 0.3×	159 0.3×	43 0.1×	105 0.4×	27	1.1k
Katayoon Goodarzi United States	12	154 0.1×	217 0.2×	294 0.5×	107 0.3×	145 0.6×	27	1.6k
Michael J. Boyle Australia	10	881 0.8×	1.2k 1.1×	464 0.8×	34 0.1×	164 0.7×	15	1.6k
Anne Camez United States	19	163 0.2×	138 0.1×	401 0.7×	125 0.4×	1.0k 4.3×	33	2.4k
Oliver Sander Germany	19	160 0.2×	90 0.1×	281 0.5×	56 0.2×	87 0.4×	73	1.0k
Qingyu Xiu China	22	440 0.4×	327 0.3×	229 0.4×	19 0.1×	372 1.6×	61	1.4k

Countries citing papers authored by Susan Flavin

Since Specialization

Citations

This map shows the geographic impact of Susan Flavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Flavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Flavin more than expected).

Fields of papers citing papers by Susan Flavin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Flavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Flavin. The network helps show where Susan Flavin may publish in the future.

Co-authorship network of co-authors of Susan Flavin

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Flavin. A scholar is included among the top collaborators of Susan Flavin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Flavin. Susan Flavin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smith, Tammy, Ka‐Ho Wong, Lisa K. Peterson, et al.. (2025). An updated, comprehensive meta-analysis of the treatment of anti-NMDAR encephalitis: Analysis, equipoise, and the urgent need for evidence over anecdote. Journal of Neuroimmunology. 405. 578651–578651. 3 indexed citations

Blauvelt, Andrew, April W. Armstrong, Richard G. Langley, et al.. (2021). Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study. Journal of Dermatological Treatment. 33(4). 2317–2324. 21 indexed citations

Langley, Richard G., Petr Arenberger, Susan Flavin, et al.. (2020). 15302 Psoriasis area and severity index component improvements at week 48 in patients treated with guselkumab compared with secukinumab: Findings from the ECLIPSE study. Journal of the American Academy of Dermatology. 83(6). AB34–AB34. 3 indexed citations

Merola, Joseph F., Shu Li, Ming-Chun Hsu, et al.. (2020). P279 Guselkumab was more effective than secukinumab in patients with plaque psoriasis and the subset of patients with self-reported PsA in the randomised, double-blind, head-to-head comparison study ECLIPSE over 1 year. Lara D. Veeken. 59(Supplement_2). 1 indexed citations

Reich, Kristian, April W. Armstrong, Richard G. Langley, et al.. (2019). Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial. The Lancet. 394(10201). 831–839. 259 indexed citations

Langley, Richard G., Tsen‐Fang Tsai, Susan Flavin, et al.. (2017). Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase III NAVIGATE trial. British Journal of Dermatology. 178(1). 114–123. 245 indexed citations

Baughman, Robert P., Marc A. Judson, Elyse E. Lower, et al.. (2016). Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial.. PubMed. 32(4). 289–95. 33 indexed citations

Raghu, Ganesh, Fernando J. Martínez, Kevin K. Brown, et al.. (2015). CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab. European Respiratory Journal. 46(6). 1740–1750. 101 indexed citations

Flavin, Susan. (2014). Consumption and Culture in Sixteenth-Century Ireland. Boydell and Brewer eBooks.

10.

Vecchio, Alfred M. Del, Patrick Branigan, Elliot S. Barnathan, et al.. (2014). Utility of animal and in vivo experimental infection of humans with rhinoviruses in the development of therapeutic agents for viral exacerbations of asthma and chronic obstructive pulmonary disease. Pulmonary Pharmacology & Therapeutics. 30. 32–43. 11 indexed citations

11.

Flavin, Susan. (2014). Consumption and Culture in Sixteenth-Century Ireland. 5 indexed citations

12.

Strange, Charlie, et al.. (2014). Social impact identified in and by the alpha-1 antitrypsin deficiency community. 1(3). 1 indexed citations

13.

Warner, Barbara, et al.. (2013). Genetics’ Influence on Patient Experiences with a Rare Chronic Disorder. Nursing Clinics of North America. 48(4). 627–636. 3 indexed citations

14.

Rennard, Stephen I., Susan Flavin, Prasheen Agarwal, Kim Hung Lo, & Elliot S. Barnathan. (2012). Long-term safety study of infliximab in moderate-to-severe chronic obstructive pulmonary disease. Respiratory Medicine. 107(3). 424–432. 23 indexed citations

15.

Richards, Thomas J., Naftali Kaminski, Fred Baribaud, et al.. (2011). Peripheral Blood Proteins Predict Mortality in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 185(1). 67–76. 260 indexed citations

16.

Baughman, Robert P., Ralph T. Shipley, Sujal R. Desai, et al.. (2009). Changes in Chest Roentgenogram of Sarcoidosis Patients During a Clinical Trial of Infliximab Therapy. CHEST Journal. 136(2). 526–535. 78 indexed citations

17.

Judson, Marc A., Robert P. Baughman, Ulrich Costabel, et al.. (2008). Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. European Respiratory Journal. 31(6). 1189–1196. 211 indexed citations

18.

Baughman, Robert P., Marjolein Drent, Mani S. Kavuru, et al.. (2006). Infliximab Therapy in Patients with Chronic Sarcoidosis and Pulmonary Involvement. American Journal of Respiratory and Critical Care Medicine. 174(7). 795–802. 473 indexed citations

19.

Goodman, Steven N., et al.. (2003). An open label study to establish dosing recommendations for nabumetone in juvenile rheumatoid arthritis.. PubMed. 30(4). 829–31. 8 indexed citations

20.

Morin, Karen H., et al.. (2002). Attitudes and Perceptions of Body Image in Postpartum African American Women: Does Weight Make a Difference?. MCN The American Journal of Maternal/Child Nursing. 27(1). 20–25. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact